Non-viral DNA delivery from porous hyaluronic acid hydrogels in mice

Biomaterials

Volumn 35, Issue 2, 2014, Pages 825-835

  Tokatlian, Talar ^a   Cam, Cynthia ^a   Segura, Tatiana ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Controlled release; Non viral gene delivery; Poly(ethylene imine); Porous hydrogel; Subcutaneous implant

Indexed keywords

CONTROLLED RELEASE; NON-VIRAL GENE DELIVERY; POLYETHYLENE IMINES; POROUS HYDROGELS; SUBCUTANEOUS IMPLANTS;

DRUG THERAPY; GENE TRANSFER; HYALURONIC ACID; MAMMALS; MOLECULAR BIOLOGY; ORGANIC ACIDS; PORE SIZE; REPAIR;

HYDROGELS;

GREEN FLUORESCENT PROTEIN; HYALURONIC ACID; NANOPARTICLE; PLASMID DNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENETIC TRANSFECTION; HYDROGEL; IMMUNOFLUORESCENCE; IN VIVO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; POROSITY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TISSUE REGENERATION; TISSUE REPAIR; VASCULARIZATION;

MUS;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE TRANSFER TECHNIQUES; HYALURONIC ACID; HYDROGELS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; NANOPARTICLES; PLASMIDS; POROSITY; TISSUE ENGINEERING; TRANSFECTION;

EID: 84886750021     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.10.014     Document Type: Article

References (76)

1. Novosel E.C., Kleinhans C., Kluger P.J. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev 2011, 63:300-311.
2. Bramfeldt H., Sabra G., Centis V., Vermette P. Scaffold vascularization: a challenge for three-dimensional tissue engineering. Curr Med Chem 2010, 17:3944-3967.
3. Laschke M.W., Menger M.D. Vascularization in tissue engineering: angiogenesis versus inosculation. Eur Surg Res 2012, 48:85-92.
4. Papavasiliou G., Cheng M.-H., Brey E.M. Strategies for vascularization of polymer scaffolds. JInvestig Med 2010, 58:838-844.
5. Chiu Y., Larson J., Isom A.J., Brey E. Generation of porous poly(ethylene glycol) hydrogels by salt leaching. Tissue Eng Part C Methods 2010, 16:905-912.
6. Chiu Y.-C., Cheng M.-H., Engel H., Kao S.-W., Larson J.C., Gupta S., et al. The role of pore size on vascularization and tissue remodeling in PEG hydrogels. Biomaterials 2011, 32:6045-6051.
7. Huang X., Zhang Y., Donahue H., Lowe T. Porous thermoresponsive-co-biodegradable hydrogels as tissue-engineering scaffolds for 3-dimensional invitro culture of chondrocytes. Tissue Eng 2007, 13:2645-2652.
8. Huang Y.C., Riddle K., Rice K.G., Mooney D.J. Long-term invivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum Gene Ther 2005, 16:609-617.
9. Jang J.H., Rives C.B., Shea L.D. Plasmid delivery invivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol Ther 2005, 12:475-483.
10. Nam Y.S., Yoon J.J., Park T.G. Anovel fabrication method of macroporous biodegradable polymer scaffolds using gas foaming salt as a porogen additive. JBiomed Mater Res 2000, 53:1-7.
11. Iyer P., Walker K.J., Madihally S.V. Increased matrix synthesis by fibroblasts with decreased proliferation on synthetic chitosan-gelatin porous structures. Biotechnol Bioeng 2011, 109:1314-1325.
12. Kang H.-W., Tabata Y., Ikada Y. Fabrication of porous gelatin scaffolds for tissue engineering. Biomaterials 1999, 20:1339-1344.
13. Kang J.Y., Chung C.W., Sung J.-H., Park B.-S., Choi J.-Y., Lee S.J., et al. Novel porous matrix of hyaluronic acid for the three-dimensional culture of chondrocytes. Int J Pharm 2009, 369:114-120.
14. Van Vlierberghe S., Cnudde V., Masschaele B., Dubruel P., De Paepe I., Jacobs P.J.S., et al. Porous gelatin cryogels as cell delivery tool in tissue engineering. JControl Release 2006, 116:e95-e98.
15. Galperin A., Long T.J., Ratner B.D. Degradable, thermo-sensitive poly(n-isopropyl acrylamide)-based scaffolds with controlled porosity for tissue engineering applications. Biomacromolecules 2010, 11:2583-2592.
16. Madden L.R., Mortisen D.J., Sussman E.M., Dupras S.K., Fugate J.A., Cuy J.L., et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A 2010, 107:15211-15216.
17. Saul J.M., Linnes M.P., Ratner B.D., Giachelli C.M., Pun S.H. Delivery of non-viral gene carriers from sphere-templated fibrin scaffolds for sustained transgene expression. Biomaterials 2007, 28:4705-4716.
18. Stachowiak A.N., Bershteyn A., Tzatzaloz E., Irvine D.J. Bioactive hydrogels with an ordered cellular structure combine interconnected macroporosity and robust mechanical properties. Adv Mater 2005, 17:399-403.
19. Peyton S.R., Kalcioglu Z.I., Cohen J.C., Runkle A.P., Van Vliet K.J., Lauffenburger D.A., et al. Marrow-derived stem cell motility in 3D synthetic scaffold is governed by geometry along with adhesivity and stiffness. Biotechnol Bioeng 2011, 108:1181-1193.
20. Stachowiak A.N., Irvine D.J. Inverse opal hydrogel-collagen composite scaffolds as a supportive microenvironment for immune cell migration. JBiomed Mater Res A 2008, 85:815-828.
21. Andreadis S.T., Geer D.J. Biomimetic approaches to protein and gene delivery for tissue regeneration. Trends Biotechnol 2006, 24:331-337.
22. Fischbach C., Mooney D.J. Polymers for pro- and anti-angiogenic therapy. Biomaterials 2007, 28:2069-2076.
23. Leach J.B., Bivens K.A., Patrick C.W., Schmidt C.E. Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 2003, 82:578-589.
24. Park Y.D., Tirelli N., Hubbell J.A. Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks. Biomaterials 2003, 24:893-900.
25. Shu X.Z., Liu Y.C., Palumbo F.S., Lu Y., Prestwich G.D. In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials 2004, 25:1339-1348.
26. Yeo Y., Highley C.B., Bellas E., Ito T., Marini R., Langer R., et al. In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model. Biomaterials 2006, 27:4698-4705.
27. Eldridge L., Moldobaeva A., Wagner E.M. Increased hyaluronan fragmentation during pulmonary ischemia. Am J Physiol Lung Cell Mol Physiol 2011, 301:L782-L788.
28. Gao F., Liu Y., He Y., Yang C., Wang Y., Shi X., et al. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol 2010, 29:107-116.
29. Voelcker V., Gebhardt C., Averbeck M., Saalbach A., Wolf V., Weih F., et al. Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp Dermatol 2008, 17:100-107.
30. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990, 61:1303-1313.
31. Sherman L., Sleeman J., Herrlich P., Ponta H. Hyaluronate receptors - key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 1994, 6:726-733.
32. Burdick J.A., Prestwich G.D. Hyaluronic acid hydrogels for biomedical applications. Adv Mater 2011, 23:H41-H56.
33. Bulpitt P., Aeschlimann D. New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. JBiomed Mater Res 1999, 47:152-169.
34. Oh E.J., Park K., Kim K.S., Kim J., Yang J.A., Kong J.H., et al. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. JControl Release 2010, 141:2-12.
35. Chung C., Burdick J.A. Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis. Tissue Eng Part A 2009, 15:243-254.
36. Gerecht S., Burdick J.A., Ferreira L.S., Townsend S.A., Langer R., Vunjak-Novakovic G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A 2007, 104:11298-11303.
37. Kim J., Park Y., Tae G., Lee K.B., Hwang C.M., Hwang S.J., et al. Characterization of low-molecular-weight hyaluronic acid-based hydrogel and differential stem cell responses in the hydrogel microenvironments. JBiomed Mater Res A 2009, 88A:967-975.
38. Pan L.J., Ren Y.J., Cui F.Z., Xu Q.Y. Viability and differentiation of neural precursors on hyaluronic acid hydrogel scaffold. JNeurosci Res 2009, 87:3207-3220.
39. Lei Y., Gojgini S., Lam J., Segura T. The spreading, migration and proliferation of mouse mesenchymal stem cells cultured inside hyaluronic acid hydrogels. Biomaterials 2011, 32:39-47.
40. Kim J., Park Y., Tae G., Lee K.B., Hwang S.J., Kim I.S., et al. Synthesis and characterization of matrix metalloprotease sensitive-low molecular weight hyaluronic acid based hydrogels. JMater Sci Mater Med 2008, 19:3311-3318.
41. Lungwitz U., Breunig M., Blunk T., Gopferich A. Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm 2005, 60:247-266.
42. Godbey W., Wu K.K., Mikos A.G. Tracking the intracellular path of poly (ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A 1999, 96:5177-5181.
43. Godbey W.T., Wu K.K., Mikos A.G. Poly(ethylenimine) and its role in gene delivery. JControl Release 1999, 60:149-160.
44. Abdallah B., Hassan A., Benoist C., Goula D., Behr J.P., Demeneix B.A. Apowerful nonviral vector for invivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 1996, 7:1947-1954.
45. Wang S., Ma N., Gao S.J., Yu H., Leong K.W. Transgene expression in the brain stem effected by intramuscular injection of polyethylenimine/DNA complexes. Mol Ther 2001, 3:658-664.
46. Gautam A., Densmore C.L., Golunski E., Xu B., Waldrep J.C. Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. Mol Ther 2001, 3:551-556.
47. Kichler A., Chillon M., Leborgne C., Danos O., Frisch B. Intranasal gene delivery with a polyethylenimine-PEG conjugate. JControl Release 2002, 81:379-388.
48. Rudolph C., Schillinger U., Plank C., Gessner A., Nicklaus P., Muller R.H., et al. Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine. Biochim Biophys Acta 2002, 1573:75-83.
49. Wiseman J.W., Goddard C.A., McLelland D., Colledge W.H. Acomparison of linear and branched polyethylenimine (PEI) with DCChol/DOPE liposomes for gene delivery to epithelial cells invitro and invivo. Gene Ther 2003, 10:1654-1662.
50. Kleemann E., Jekel N., Dailey L.A., Roesler S., Fink L., Weissmann N., et al. Enhanced gene expression and reduced toxicity in mice using polyplexes of low-molecular-weight poly(ethylene imine) for pulmonary gene delivery. JDrug Target 2009, 17:638-651.
51. Segura T., Schmokel H., Hubbell J.A. RNA interference targeting hypoxia inducible factor 1[alpha] reduces post-operative adhesions in rats. JSurg Res 2007, 141:162-170.
52. Wong S.P., Argyros O., Howe S.J., Harbottle R.P. Systemic gene transfer of polyethylenimine (PEI)-plasmid DNA complexes to neonatal mice. JControl Release 2011, 150:298-306.
53. Aoki K., Furuhata S., Hatanaka K., Maeda M., Remy J.S., Behr J.P., et al. Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity. Gene Ther 2001, 8:508-514.
54. Coll J.L., Chollet P., Brambilla E., Desplanques D., Behr J.P., Favrot M. Invivo delivery to tumors of DNA complexed with linear polyethylenimine. Hum Gene Ther 1999, 10:1659-1666.
55. Iwai M., Harada Y., Tanaka S., Muramatsu A., Mori T., Kashima K., et al. Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma invivo by using an Epstein-Barr virus-based plasmid vector. Biochem Biophys Res Commun 2002, 291:48-54.
56. Lei P., Padmashali R.M., Andreadis S.T. Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels. Biomaterials 2009, 30:3790-3799.
57. Kong H.J., Kim E.S., Huang Y.C., Mooney D.J. Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA. Pharm Res 2008, 25:1230-1238.
58. Fukunaka Y., Iwanaga K., Morimoto K., Kakemi M., Tabata Y. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. JControl Release 2002, 80:333-343.
59. Jang J.-H., Houchin T.L., Shea L.D. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev Med Devices 2004, 1:127-138.
60. Wieland J.A., Houchin-Ray T.L., Shea L.D. Non-viral vector delivery from PEG-hyaluronic acid hydrogels. JControl Release 2007, 120:233-241.
61. Lei Y., Segura T. DNA delivery from matrix metalloproteinase degradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymal stem cells. Biomaterials 2009, 30:254-265.
62. Lei Y., Ng Q.K.T., Segura T. Two and three-dimensional gene transfer from enzymatically degradable hydrogel scaffolds. Microsc Res Tech 2010, 73:910-917.
63. Gojgini S., Tokatlian T., Segura T. Utilizing cell-matrix interactions to modulate gene transfer to stem cells inside hyaluronic acid hydrogels. Mol Pharm 2011, 8:1582-1591.
64. Lei Y., Huang S., Sharif-Kashani P., Chen Y., Kavehpour P., Segura T. Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds. Biomaterials 2010, 31:9106-9116.
65. Lei Y., Rahim M., Ng Q., Segura T. Hyaluronic acid and fibrin hydrogels with concentrated DNA/PEI polyplexes for local gene delivery. JControl Release 2011, 153:255-261.
66. Shepard J.A., Virani F.R., Goodman A.G., Gossett T.D., Shin S., Shea L.D. Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis. Biomaterials 2012, 33:7412-7421.
67. Tokatlian T., Cam C., Siegman S.N., Lei Y., Segura T. Design and characterization of microporous hyaluronic acid hydrogels for invitro gene transfer to mMSCs. Acta Biomater 2012, 8:3921-3931.
68. Schrementi M.E., Ferreira A.M., Zender C., DiPietro L.A. Site-specific production of TGF-β in oral mucosal and cutaneous wounds. Wound Repair Regen 2008, 16:80-86.
69. Szpaderska A.M., Zuckerman J.D., DiPietro L.A. Differential injury responses in oral mucosal and cutaneous wounds. JDent Res 2003, 82:621-626.
70. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
71. Ehrbar M., Zeisberger S.M., Raeber G.P., Hubbell J.A., Schnell C., Zisch A.H. The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials 2008, 29:1720-1729.
72. Moon J.J., Saik J.E., Poché R.A., Leslie-Barbick J.E., Lee S.-H., Smith A.A., et al. Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 2010, 31:3840-3847.
73. Silva E.A., Mooney D.J. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. JThromb Haemost 2007, 5:590-598.
74. Zisch A.H., Lutolf M.P., Ehrbar M., Raeber G.P., Rizzi S.C., Davies N., et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J 2003, 17:2260-2262.
75. Peppas N.A., Hilt J.Z., Khademhosseini A., Langer R. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv Mater 2006, 18:1345-1360.
76. Ehrbar M., Djonov V.G., Schnell C., Tschanz S.A., Martiny-Baron G., Schenk U., et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 2004, 94:1124-1132.